Histogen Inc. has appointed Susan R. Windham-Bannister, Ph.D. to its Board of Directors. Dr. Windham-Bannister is an internationally recognized expert in innovation, market access and market optimization strategies. Dr. Windham-Bannister currently serves as the President and CEO of Biomedical Growth Strategies, LLC and as immediate past President and CEO of the Massachusetts Life Sciences Center (MLSC), a state-funded investment organization charged with administering a $1 billion Life Sciences investment fund created by Governor Deval Patrick in June 2008. These advisory firms and other organizations leverage Dr. Windham-Bannister's experience as a business strategist. Mr. Hayden Zhang, who will be stepping down from the Board of Directors, for his many years of service to Histogen. Mr. Zhang became a director of the Company in August 2016, when an affiliate of Huapont Life Sciences Co Ltd, a company with which Mr. Zhang is affiliated, made a strategic investment into Histogen.